UoH, Dr Reddy’s win patent for psoriasis treatment mode
Hyderabad: A team of researchers from the School of Life Sciences, University of Hyderabad and Dr.Reddy’s Institute of Life Sciences have validated the 12R-LOX enzyme as the target for development of anti-psoriasis drugs. According to an official note from the University of Hyderabad, a recognized feature of psoriasis and other proliferative dermatoses (skin defects) was […]
Hyderabad: A team of researchers from the School of Life Sciences, University of Hyderabad and Dr.Reddy’s Institute of Life Sciences have validated the 12R-LOX enzyme as the target for development of anti-psoriasis drugs.
According to an official note from the University of Hyderabad, a recognized feature of psoriasis and other proliferative dermatoses (skin defects) was the accumulation in the skin of the unusual arachidonic acid metabolite, 12R-hydroxyeicosatetraenoic acid (12R-HETE), a product of 12R-Lipoxygenase (12R-LOX).
A team of researchers from the UoH, comprising Prof. P. Reddanna, Dr. Kumar Reddy and Dr. Nooruddin Khan, along with Harshavardhan Bhuktar, Sharda Shukla and Manojit Pal from Dr. Reddy’s, through a series of experiments, validated the 12R-LOX as the target for the development of anti-psoriasis drugs. The experiments included generation of 12R-LOX overexpressing transgenic mice and efficacy of 12R-LOX inhibitors.
The note said that the lead compounds showing efficacy in vitro on the target enzyme and in vivo on animal models were granted Indian Patent No. 377565. A patent cooperation treaty (PCT) has also been filed for this invention, the note said.
The invention was the outcome of a collaborative project between the two institutions funded jointly by the Department of Science and Technology and Dr Reddy’s for a project on ‘12-R-Lipoxygenase as Target for Discovery and Development of Drugs Against Psoriasis’.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
Related News
